TREACE MEDICAL CONCEPTS, INC.
SEC 4 · Filed
0001193125-26-047313Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Feb 10, 2026
- Security
- Stock Option (Right to Buy)
- Shares
-
16,875
- Price per share
-
0.00
Structured facts
{
"code": "M",
"date": "2026-02-10",
"direction": "D",
"exercise_price": "1.05",
"expiration": "2027-01-30",
"footnotes": {
"F2": "The stock option vested in equal annual installments over 4 years, commencing on January 30, 2017 with the last installment vesting on January 30, 2021."
},
"owners": [
{
"cik": "0001856371",
"name": "Scanlan Sean F.",
"roles": [
"officer"
],
"title": "Chief Innovation Officer"
}
],
"ownership": "D",
"post_shares": "0",
"price": "0.00",
"row": 1,
"rule_10b5_1": "false",
"security": "Stock Option (Right to Buy)",
"shares": "16875",
"table": "II",
"underlying_security": "Common Stock",
"underlying_shares": "16875"
}Insider transactionsEvent date Feb 10, 2026
- Security
- Common Stock
- Shares
-
16,875
- Price per share
-
1.05
Structured facts
{
"code": "M",
"date": "2026-02-10",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Includes 511, 291 restricted stock units."
},
"owners": [
{
"cik": "0001856371",
"name": "Scanlan Sean F.",
"roles": [
"officer"
],
"title": "Chief Innovation Officer"
}
],
"ownership": "D",
"post_shares": "706474",
"price": "1.05",
"row": 1,
"rule_10b5_1": "false",
"security": "Common Stock",
"shares": "16875",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}